152 related articles for article (PubMed ID: 12765779)
1. Synthesis of new conformationally constrained pentasaccharides as molecular probes to investigate the biological activity of heparin.
Sisu E; Tripathy S; Mallet JM; Driguez PA; Hérault JP; Sizun P; Herbert JM; Petitou M; Sinay P
Biochimie; 2003; 85(1-2):91-9. PubMed ID: 12765779
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a 3-deoxy-L-iduronic acid containing heparin pentasaccharide to probe the conformation of the antithrombin III binding sequence.
Lei PS; Duchaussoy P; Sizun P; Mallet JM; Petitou M; Sinaÿ P
Bioorg Med Chem; 1998 Aug; 6(8):1337-46. PubMed ID: 9784873
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of conformationally locked L-iduronic acid derivatives: direct evidence for a critical role of the skew-boat 2S0 conformer in the activation of antithrombin by heparin.
Das SK; Mallet JM; Esnault J; Driguez PA; Duchaussoy P; Sizun P; Herault JP; Herbert JM; Petitou M; Sinaÿ P
Chemistry; 2001 Nov; 7(22):4821-34. PubMed ID: 11763451
[TBL] [Abstract][Full Text] [Related]
4. Conformational transitions induced in heparin octasaccharides by binding with antithrombin III.
Guerrini M; Guglieri S; Beccati D; Torri G; Viskov C; Mourier P
Biochem J; 2006 Oct; 399(2):191-8. PubMed ID: 16796563
[TBL] [Abstract][Full Text] [Related]
5. Degeneracy of the Antithrombin Binding Sequence in Heparin: 2-O-Sulfated Iduronic Acid Can Replace the Critical Glucuronic Acid.
Elli S; Stancanelli E; Wang Z; Petitou M; Liu J; Guerrini M
Chemistry; 2020 Sep; 26(51):11814-11818. PubMed ID: 32515841
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
Desai UR; Petitou M; Björk I; Olson ST
Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
[TBL] [Abstract][Full Text] [Related]
7. Combined NMR and molecular modeling study of an iduronic acid-containing trisaccharide related to antithrombotic heparin fragments.
Cros S; Petitou M; Sizun P; Pérez S; Imberty A
Bioorg Med Chem; 1997 Jul; 5(7):1301-9. PubMed ID: 9377090
[TBL] [Abstract][Full Text] [Related]
8. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence.
Guerrini M; Elli S; Mourier P; Rudd TR; Gaudesi D; Casu B; Boudier C; Torri G; Viskov C
Biochem J; 2013 Jan; 449(2):343-51. PubMed ID: 23083208
[TBL] [Abstract][Full Text] [Related]
9. Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor.
Nieto L; Canales Á; Giménez-Gallego G; Nieto PM; Jiménez-Barbero J
Chemistry; 2011 Sep; 17(40):11204-9. PubMed ID: 21922554
[TBL] [Abstract][Full Text] [Related]
10. The effect of a reducing-end extension on pentasaccharide binding by antithrombin.
Belzar KJ; Dafforn TR; Petitou M; Carrell RW; Huntington JA
J Biol Chem; 2000 Mar; 275(12):8733-41. PubMed ID: 10722716
[TBL] [Abstract][Full Text] [Related]
11. Conformation of heparin pentasaccharide bound to antithrombin III.
Hricovíni M; Guerrini M; Bisio A; Torri G; Petitou M; Casu B
Biochem J; 2001 Oct; 359(Pt 2):265-72. PubMed ID: 11583572
[TBL] [Abstract][Full Text] [Related]
12. Re-visiting the structure of heparin.
Casu B; Naggi A; Torri G
Carbohydr Res; 2015 Feb; 403():60-8. PubMed ID: 25088334
[TBL] [Abstract][Full Text] [Related]
13. Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue.
Torri G; Casu B; Gatti G; Petitou M; Choay J; Jacquinet JC; Sinaÿ P
Biochem Biophys Res Commun; 1985 Apr; 128(1):134-40. PubMed ID: 3985961
[TBL] [Abstract][Full Text] [Related]
14. 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site.
Petitou M; Casu B; Lindahl U
Biochimie; 2003; 85(1-2):83-9. PubMed ID: 12765778
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of heparin. O-sulfation of the antithrombin-binding region.
Kusche M; Bäckström G; Riesenfeld J; Petitou M; Choay J; Lindahl U
J Biol Chem; 1988 Oct; 263(30):15474-84. PubMed ID: 3139669
[TBL] [Abstract][Full Text] [Related]
16. Conformational flexibility of a synthetic glycosylaminoglycan bound to a fibroblast growth factor. FGF-1 recognizes both the (1)C(4) and (2)S(O) conformations of a bioactive heparin-like hexasaccharide.
Canales A; Angulo J; Ojeda R; Bruix M; Fayos R; Lozano R; Giménez-Gallego G; Martín-Lomas M; Nieto PM; Jiménez-Barbero J
J Am Chem Soc; 2005 Apr; 127(16):5778-9. PubMed ID: 15839662
[TBL] [Abstract][Full Text] [Related]
17. Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide.
Westerduin P; van Boeckel CA; Basten JE; Broekhoven MA; Lucas H; Rood A; van der Heijden H; van Amsterdam RG; van Dinther TG; Meuleman DG
Bioorg Med Chem; 1994 Nov; 2(11):1267-80. PubMed ID: 7757423
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Heparan Sulfate- and Dermatan Sulfate-Related Oligosaccharides via Iterative Chemoselective Glycosylation Exploiting Conformationally Disarmed [2.2.2] l-Iduronic Lactone Thioglycosides.
Jeanneret RA; Dalton CE; Gardiner JM
J Org Chem; 2019 Dec; 84(23):15063-15078. PubMed ID: 31674785
[TBL] [Abstract][Full Text] [Related]
19. Toward synthesis of the isosteric sulfonate analogues of the AT-III binding domain of heparin.
Herczeg M; Lázár L; Borbás A; Lipták A; Antus S
Org Lett; 2009 Jun; 11(12):2619-22. PubMed ID: 19473011
[TBL] [Abstract][Full Text] [Related]
20. An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically modified heparin, and heparin-derived oligosaccharides.
Chuang WL; Christ MD; Peng J; Rabenstein DL
Biochemistry; 2000 Apr; 39(13):3542-55. PubMed ID: 10736153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
